Skip to content

A Study on Mandurathi Kudineer in the management of Kaleeral Noi (Non-Alcoholic Fatty Liver Disease).

An Open Clinical Trial to evaluate the effectiveness of Mandurathi Kudineer in the management of Kaleeral Noi (Non-Alcoholic Fatty Liver Disease) among out patients attending Ayothidoss Pandithar Hospital, National Institute Of Siddha. - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068735
Enrollment
20
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Mandurathi Kudineer: 5 Grams bd made into decoction for 90 days Control Intervention1: N/A: N/A

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants with USG findings suggestive of fatty liver grades I , II, III showing fatty infiltration of the liver

Exclusion criteria

Exclusion criteria: 1.Participants who are known to consume alcohol[alcohol history taken from participants close relatives] 2.k/c/o chronic kidney diseases, cardiovascular diseases 3.Participants with known liver diseases such as viral hepatitis, autoimmune disorders, biliary disorder, liver abscess, cirrhosis and malignancy 4.Pregnant and lactating women. 5.Participants who have taken drugs that interfere with the lipid metabolism within 3 months before screening such as methotrexate,sodium valporate,amiodarone and glucocorticoids.

Design outcomes

Primary

MeasureTime frame
Reduction in the Grades of fatty liver will be assessed by Ultra Sonogram before and after treatment.Timepoint: 6 MONTHS

Secondary

MeasureTime frame
1.Changes in Liver function test,lipid profile and fasting blood sugar will be assessed before and after treatment 2.Changes in waist circumference and Body Mass Index will be assessed before and after treatment Timepoint: 6 MONTHS

Countries

India

Contacts

Public ContactDr T Lakshmikantham

National Institute of Siddha

drlakshmiramasway@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026